You are here

Isodiol International Inc.

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Diversified Industries
Symbol: 
ISOL
CSE Index: 
Currency: 

Isodiol International Inc. ("Isodiol") is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions.

Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products.

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its consumer products portfolio and continued international expansion into Latin America, Asia, and Europe.

You are here

Isodiol International Inc. (ISOL)

SEDAR Information

Company Info

Address
Suite 1000, 595 Burrard Street
P.O. Box 49290
Vancouver, BC V7X 1S8
Canada
Phone
604-409-4409
Email
ir@isodiol.com
Website
https://isodiol.com/
Listing date
Tuesday, July 8, 2014
Transfer Agent
Computershare Investor Services Inc.
Email
ir@isodiol.com
Auditor
Davidson & Company LLP, Chartered Professional Accountants

Capitalization

Issued & Outstanding: 
128534359
Reserved for Issuance: 
2607754

Company Officers

Marcos Agramont, Chief Executive Officer, Chief Operating Officer
Andrew Alvis, President and Interim Chief Financial Officer

Bulletins

06/12/2021

2021-1206 - Delist - Isodiol International Inc. (ISOL)

Le 6 décembre/December 2021

The common shares of Isodiol International Inc. will be delisted at the market close today December 6, 2021.

Isodiol International is currently suspended. See bulletin 2020-1214.

___________________

Les actions ordinaires de Isodiol International Inc. seront radiées de la cote à la clôture du marché aujourd'hui, le 6 décembre 2021.